
Bipartisan antitrust legislation aimed at Amazon, Apple, Facebook, and Google could hurt US competitiveness and give foreign adversaries access to sensitive information, according to a new report from a tech industry group.
According to Bloomberg, the white paper from the Computer & Communications Industry Association, which counts all four companies among its members, argues that a series of antitrust bills approved by the House Judiciary Committee in June would help foreign competitors, including Chinese and Russian companies, by placing severe restrictions solely on US tech giants.
Many of the paper’s arguments echo warnings from technology groups and lawmakers who opposed the measures during a June hearing.
In part because of their size and ability to innovate, US tech companies are valuable partners for the US government and intelligence community to counter global cyber threats, according to Dan Coats, a former Republican senator and director of national intelligence who now works at law firm King & Spalding and helped write the report.
Related: How the House Antitrust Bills Preserve Platforms’ Editorial Discretion and Spur Consumer Choice
“A lot of people are talking about the pros and cons of the economic impacts and innovation, which is legitimate, but also take a look at the national security,” Coats said in an interview Friday, September 10. He urged lawmakers to consult with House and Senate intelligence committees and federal agencies before voting on antitrust legislation that he said could have unintended consequences.
The House Judiciary Committee approved a series of six bipartisan antitrust bills, and four of them target Amazon, Apple, Facebook, and Google. It’s not clear when or if those four bills will get a vote on the House floor. Senators on the antitrust subcommittee have said they plan to introduce some similar measures.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas